The Serendipity Around Ejection Fraction – a review of history, fortuity, and quasi-functionality of an applauded metric

Autor: Kerkhof, PL, Diaz-Navarro, Rienzi A., Heyndrickx, G.R., Handly, Neal

Publikováno v: Kerkhof, PL, Diaz-Navarro, R A, Heyndrickx, G R & Handly, N 2022, ' La serendipia en torno la fracción de eyección: una revisión de la historia, la casualidad y la cuasi-funcionalidad de una métrica aplaudida ', Revista Medica de Chile, vol. 150, no. 2, pp. 232-240 . https://doi.org/http://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/9479
Revista Medica de Chile, 150(2), 232-240. Sociedad Medica de Santiago

Ejection fraction (EF) is defined by the ratio of end-systolic volume (ESV) and end-diastolic volume (EDV). The resulting fraction is a dimensionless number, rendering the interpretation of EF ambiguous and possibly misleading. Notwithstanding these

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3968ae4c5541961b1b5b71024ef3880a
https://research.vumc.nl/en/publications/d1e634f0-46fe-4b32-9f80-5b0b24592fc8

Cardiopoietic cell therapy for advanced ischaemic heart failure: Results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial

Autor: Bartunek, J. Terzic, A. Davison, B.A. Filippatos, G.S. Radovanovic, S. Beleslin, B. Merkely, B. Musialek, P. Wojakowski, W. Andreka, P. Horvath, I.G. Katz, A. Dolatabadi, D. El Nakadi, B. Arandjelovic, A. Edes, I. Seferovic, P.M. Obradovic, S. Vanderheyden, M. Jagic, N. Petrov, I. Atar, S. Halabi, M. Gelev, V.L. Shochat, M.K. Kasprzak, J.D. Sanz-Ruiz, R. Heyndrickx, G.R. Nyolczas, N. Legrand, V. Guédès, A. Heyse, A. Moccetti, T. Fernandez-Aviles, F. Jimenez-Quevedo, P. Bayes-Genis, A. Hernandez-Garcia, J.M. Ribichini, F. Gruchala, M. Waldman, S.A. Teerlink, J.R. Gersh, B.J. Povsic, T.J. Henry, T.D. Metra, M. Hajjar, R.J. Tendera, M. Behfar, A. Alexandre, B. Seron, A. Stough, W.G. Sherman, W. Cotter, G. Wijns, W.

Aims Cardiopoietic cells, produced through cardiogenic conditioning of patients' mesenchymal stem cells, have shown preliminary efficacy. The Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial aimed to validate cardiopoiesis-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::8cd84c803783a6bcc3f04c55b80ddf94
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3108863

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cyclic flow variations after angioplasty: a rare phenomenon predictive of immediate complications

Autor: Sunamura, M., di Mario, C., Piek, J.J., Schroeder, E., Vrints, Christiaan, Probst, P., Heyndrickx, G.R., Fleck, E., Serruys, P.W.

Publikováno v: American heart journal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2097::919e5f8211a9c6d1ebb45fe57655f1bf
https://hdl.handle.net/10067/147200151162165141

Transstenotic coronary pressure gradient measurement in humans: in vitro and in vivo evaluation of a new pressure monitoring angioplasty guide wire

Autor: de Bruyne, B., Pijls, N.H.J., Paulus, Walter J., Vantrimpont, P.J., Sys, Stanislas, Heyndrickx, G.R.

Publikováno v: Journal of the American College of Cardiology

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2097::bed8b155c9ab4d5bf8e2e367043766aa
https://hdl.handle.net/10067/67540151162165141